Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBIVA trial: 7 versus 14 days of intravenous antibiotics for bronchiectasis exacerbation
ISRCTN14057228Phase 4Recruiting
- Sponsor
- University of Edinburgh
- Start
- Jul 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of meropenem in bronchiectasis, sponsored by University of Edinburgh. Started Jul 2023; status: recruiting.
02
Drugs
meropenem
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ISRCTN14057228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14057228.